Why the study?
Cardiovascular event risk, healthcare resource utilization, and costs had not been elucidated among patients with hypertension and treated insomnia.
Does treated insomnia increase cardiovascular event risk, healthcare resource utilization, and costs in adult patients with hypertension?
Does treated insomnia increase cardiovascular event risk, healthcare resource utilization, and costs in adult patients with hypertension?
Treated insomnia in hypertensive patients is associated with a 2.4-fold increased risk of cardiovascular events and significantly higher healthcare costs.
Treated insomnia in hypertension may signal higher CV risk and costs; leaves open causal effects and practice implications.
Background: Cardiovascular (CV) event risk, healthcare resource utilization (HCRU) and costs have not been elucidated among hypertension patients with treated insomnia (H + TI). Materials & methods: Adult patients with H + TI were identified in IBM MarketScan databases. H + TI patients were matched 1:1 on age and sex to controls with hypertension but without sleep disorders. Multivariable models were used to estimate associations between treated insomnia and CV event risk, HCRU and costs. Results: In total, 81,502 H + TI patients (mean age = 62 years, 53% female) were matched. Relative to controls, H + TI patients were 2.4 times as likely to have CV events. H + TI patients incurred higher costs per patient per month (US$2343 vs US$1013). Conclusion: Treated insomnia was associated with higher costs and HRCU in hypertension patients.
No takes yet. Share an insight, caveat, or question.
Wickwire et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: